# Brightonix Imaging

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brightonix-imaging

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.brtnx.com
- Total disclosed funding: $15M
- Latest round: Series B (Jan 13, 2026)
- Investors on record: 6

## About

Based in Seoul, South Korea, and founded in 2016, Brightonix Imaging Inc., a.k.a. Brightonix Imaging operates as a healthcare IT company that intends to provide AI-based PET analysis software and brain PET (Positron Emission Tomography) (positron tomography) solutions. In May 2022, Brightonix Imaging Inc. raised KRW 6 billion in a Series A funding from Hana Ventures and T.S. Investment. As of May 2022, Lee Jae-sung is the CEO of the company.

The company provides automated quantification software for amyloid-ß PET, tau PET, dopamine transporter PET, and FDG PET. Brightonix Imaging also offers clinical devices, such as brain-dedicated PET, as well as preclinical devices, such as SiPM-based small animal PET systems for hybrid imaging and standalone use.

## Funding rounds

- Series B, Jan 13, 2026, $2.1M — K2 Investment Partners
- Series B, Nov 26, 2025, $5.8M — T.S. Investment, Hana Ventures
- Series A, May 31, 2022, $4.8M — T.S. Investment, Hana Ventures
- Series A, Apr 12, 2019, $2M — KNet Investment Partners
- Seed, Sep 1, 2018 — Korea Tech Incubator for Startup, Seoul Technology Holdings

## Investors

- Korea Tech Incubator for Startup — Seed
- Seoul Technology Holdings (https://capitalatlas.ai/funds/seoul-technology-holdings) — Seed
- KNet Investment Partners (https://capitalatlas.ai/funds/knet-investment-partners) — Series A
- T.S. Investment (https://capitalatlas.ai/funds/t-s-investment) — Series A, Series B
- Hana Ventures — Series A, Series B
- K2 Investment Partners (https://capitalatlas.ai/funds/k2-investment-partners) — Series B